Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.

Yu, Devin; Ling, Leona E; Krumme, Alexis A; Tjoa, May Lee; Moise, Kenneth J

Yu, Devin; Ling, Leona E; Krumme, Alexis A; Tjoa, May Lee; Moise, Kenneth J.

Afiliação

Yu D; Janssen Research & Development, LLC, Cambridge, MA (Drs Yu, Ling, Krumme, and Tjoa).
Ling LE; Janssen Research & Development, LLC, Cambridge, MA (Drs Yu, Ling, Krumme, and Tjoa).
Krumme AA; Janssen Research & Development, LLC, Cambridge, MA (Drs Yu, Ling, Krumme, and Tjoa).
Tjoa ML; Janssen Research & Development, LLC, Cambridge, MA (Drs Yu, Ling, Krumme, and Tjoa).
Moise KJ; The Department of Women's Health, Dell Medical School, The University of Texas at Austin, Austin, TX (Dr Moise).

AJOG Glob Rep ; 3(2): 100203, 2023 May.

Article em En | MEDLINE | ID: mdl-37229151

Palavras-chave

National Hospital Discharge Survey; alloimmunization; blood disorder; cesarean delivery; feto-maternal hemorrhage; hemolytic disease of the fetus and newborn (HDFN); hospital discharge status; hospital length of stay; inpatient visits; observational cohort study; retrospective

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: AJOG Glob Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google